Comment re: "Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention" and "aberrant crypt foci in the adenoma prevention with celecoxib trial"

Peter Lance; Stanley R. Hamilton

doi:10.1158/1940-6207.CAPR-08-0132

Comment re: "Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention" and "aberrant crypt foci in the adenoma prevention with celecoxib trial"

Peter Lance, Stanley R. Hamilton

Pathology

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	216
Number of pages	1
Journal	Cancer Prevention Research
Volume	1
Issue number	3
DOIs	https://doi.org/10.1158/1940-6207.CAPR-08-0132
State	Published - Aug 2008

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1940-6207.CAPR-08-0132

Cite this

@article{0738925340a14c92a33d08b82418390d,

title = "Comment re: {"}Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention{"} and {"}aberrant crypt foci in the adenoma prevention with celecoxib trial{"}",

author = "Peter Lance and Hamilton, {Stanley R.}",

year = "2008",

month = aug,

doi = "10.1158/1940-6207.CAPR-08-0132",

language = "English (US)",

volume = "1",

pages = "216",

journal = "Cancer Prevention Research",

issn = "1940-6207",

publisher = "American Association for Cancer Research Inc.",

number = "3",

}

TY - JOUR

T1 - Comment re

T2 - "Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention" and "aberrant crypt foci in the adenoma prevention with celecoxib trial"

AU - Lance, Peter

AU - Hamilton, Stanley R.

PY - 2008/8

Y1 - 2008/8

UR - http://www.scopus.com/inward/record.url?scp=58349107214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58349107214&partnerID=8YFLogxK

U2 - 10.1158/1940-6207.CAPR-08-0132

DO - 10.1158/1940-6207.CAPR-08-0132

M3 - Letter

AN - SCOPUS:58349107214

SN - 1940-6207

VL - 1

SP - 216

JO - Cancer Prevention Research

JF - Cancer Prevention Research

IS - 3

ER -

Comment re: "Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention" and "aberrant crypt foci in the adenoma prevention with celecoxib trial"

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this